ArticleJTO clinical and research reports2024

Real-World Pharmacokinetics, Effectiveness, and Safety of Atezolizumab in Patients With Unresectable Advanced or Recurrent NSCLC: An Exploratory Study of J-TAIL.

Shigehiro Yagishita et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.